Medigus Broadens Availability of MUSE™ Through Distribution Agreement With ADMEDICS AG in Switzerland and Liechtenstein
New agreement expands accessibility of MUSE™ in new markets
Medigus Presents New Data Demonstrating the MUSE™ System Improves GERD Symptoms and Reduces Proton Pump Inhibitor Reliance
Medigus Ltd. announced that the first MUSE procedures were performed in Switzerland by Prof. Dr. Gerhard Treiber at the Center for Digestive Diseases (Gastrozentrum) at Hirslanden Clinic in Aarau.
Medigus Ltd. announced the completion of the first MUSE procedure in China.
Medigus Receives Approval for Commencement of the First Multi-Center MUSE™ Clinical Study from CFDA in China
Medigus Ltd. announced that the China Food and Drug Administration, or CFDA, has approved the commencement of the first multi-center MUSE™ Clinical Study in China.
First purchase order (PO) for the MUSE™ system in Italy from INNOVAMEDICA S.p.A.
No immediate effect on the listing or trading of Medigus' American depositary shares on the NASDAQ Stock Market.
Vice President of Sales and Marketing, Yaron Silberman, to Present at the Inventors Corner Session on January 4, 2017 at 5:50pm IST